Latest Cancer treatments Stories
Study to Enroll 20 More Subjects PRINCETON, N.J., March 3, 2015 /PRNewswire/ -- Soligenix, Inc.
Researchers at MIT have developed a new device which uses nanoparticles to block the genes that confers drug resistance, offering a new way to prevent chemotherapy and other treatments from losing their effectiveness in treating cancer over time.
Close competition encourages established manufacturers to broaden the drug pipeline for targeted therapies, finds Frost & Sullivan LONDON, March 3, 2015 /PRNewswire/ -- Although lung
NEW YORK, March 2, 2015 /PRNewswire/ -- Delcath Systems, Inc.
- New, long-term preliminary data from Phase II STAND trial to be presented at 2015 Genitourinary Cancers Symposium (ASCO GU) LAVAL, Quebec, Feb.
The Hong Kong Polytechnic University (PolyU) entered into a license agreement on 13 February 2015 with a global oncology specialist company, Kinex Pharmaceuticals, Inc.
A Follow-On Combination Trial in First-Line Ovarian Cancer in the Neo-Adjuvant Setting Has Been Accepted by FDA LAWRENCEVILLE, N.J., Feb.
NEW YORK, Feb. 19, 2015 /PRNewswire/ -- Novogen presented yesterday (Wednesday February 18) to an audience of stockholders, analysts, investors and investment bankers.
DUBLIN, Feb .11, 2015 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/ptgkrh/drug_delivery_in)
The U.S. healthcare system is about to be deluged with diagnoses of early-stage lung cancers. SAN RAFAEL, Calif., Feb.
- A serpent whose bite was fabled to produce intense thirst.
More Images (3 images) »